Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Amikacin Eases MAC Lung Disease in First-Line Treatment

Amikacin Eases MAC Lung Disease in First-Line Treatment
ShareXFacebook

(MedPage Today) -- Amikacin liposome inhalation suspension (ALIS) improved symptoms and infection clearance in treatment-naive Mycobacterium avium complex (MAC) lung disease, the ENCORE trial showed. For the primary endpoint, the aminoglycoside...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Migraine With Aura Tied to Higher Stroke Risk
MedPage Today

Migraine With Aura Tied to Higher Stroke Risk

(MedPage Today) -- Middle-aged and older adults who had migraine with aura had a greater risk of subsequent stroke, a study of 11,000 people showed. Over 6 years, migraine with aura was associated with a 73% higher risk of ischemic stroke compared...

Read more →
Advertisement